Korean J Nephrol.
2002 Mar;21(2):185-189.
Route of Administration of rHuEPO to Patients with End Stage Renal Diseases: Efficacy and Economic Considerations
- Affiliations
-
- 1Department of Internal Medicine, College of Medicine, Hanyang University, Seoul, Korea. kangjm@hanyang.ac.kr
Abstract
- No abstract available.
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Long-term Effect of Desferrioxamine to rHuEPO Regident Anemia in Hemodialysis Patients
- Effects of adjuvant androgen on anemia and nutritional parameters in chronic hemodialysis patients using low-dose recombinant human erythropoietin
- Acquired Pure Red Cell Aplasia due to Anti-Erythropoietin Antibodies in a Patient Undergoing Hemodialysis
- Effects of Recombinant Human Erythropoietin on Intradialytic Changes in Plasma Concentration of Vasoactive Substances
- End-stage renal failure in 124 children: analysis of etiology, age and interal from early renal failure to the end stage
